Details of the Drug Reposition

General Information of This Drug (ID: DMY5JEP)

• Drug Name: Mezlocillin (DMY5JEP)
• Synonyms: Mezlin; Mezlocilina; Mezlocillinum; Mezlocillin (USAN/INN); (2S,5R,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl-2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-3,3-dimethyl-6-{[(2R)-2-({[3-(methylsulfonyl)-2-oxoimidazolidin-1-yl]carbonyl}amino)-2-phenylacetyl]amino}-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6beta-{(2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido}-2,2-dimethylpenam-3alpha-carboxylic acid; 6beta-{(2R)-2-[3-(methanesulfonyl)-2-oxoimidazolidine-1-carboxamido]-2-phenylacetamido}penicillanic acid
• Therapeutic Class: Antibiotics
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

4 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Aspiration pneumonia	DIS0DGX4	N.A.	Approved	[1]
Acute gonococcal cervicitis	DIS4LKDT	N.A.	Approved	[1]
Bacteremia	DIS6N9RZ	1A73	Approved	[1]
Urinary tract infection	DISMT6UV	GC08	Approved	[2]

1 Withdrawn Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Acute gonococcal endometritis	DISZ8BW7	N.A.	Withdrawn	[3]

1 Discontinued in Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Gonorrhea	DISQ5AO6	1A7Z	Discontinued in Phase 1	[4]

References

• [1] Mezlocillin FDA Label
• [2] FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 050549.
• [3] ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML)
• [4] Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer